FOXD4L5
gene geneOn this page
Also known as bA15J10.2OTTHUMG00000013332
Summary
FOXD4L5 (forkhead box D4 like 5, HGNC:18522) is a protein-coding gene on chromosome 9q21.11, encoding Forkhead box protein D4-like 5 (Q5VV16).
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in anatomical structure morphogenesis; cell differentiation; and regulation of transcription by RNA polymerase II. Predicted to be located in chromatin.
Source: NCBI Gene 653427 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 165 total
- MANE Select transcript:
NM_001126334
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18522 |
| Approved symbol | FOXD4L5 |
| Name | forkhead box D4 like 5 |
| Location | 9q21.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA15J10.2, OTTHUMG00000013332 |
| Ensembl gene | ENSG00000204779 |
| Ensembl biotype | protein_coding |
| Entrez | 653427 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000377420
RefSeq mRNA: 1 — MANE Select: NM_001126334
NM_001126334
CCDS: CCDS47977
Canonical transcript exons
ENST00000377420 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001681769 | 65282101 | 65285209 |
Expression profiles
Bgee: expression breadth broad, 72 present calls, max score 82.70.
Top tissues by expression
90 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.70 | gold quality |
| cortical plate | UBERON:0005343 | 61.79 | gold quality |
| right uterine tube | UBERON:0001302 | 58.63 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 54.68 | gold quality |
| cerebellum | UBERON:0002037 | 54.66 | gold quality |
| cerebellar cortex | UBERON:0002129 | 54.63 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 54.54 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 53.20 | gold quality |
| stromal cell of endometrium | CL:0002255 | 50.99 | silver quality |
| granulocyte | CL:0000094 | 50.94 | silver quality |
| Ammon’s horn | UBERON:0001954 | 50.91 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 50.60 | gold quality |
| prefrontal cortex | UBERON:0000451 | 50.37 | gold quality |
| cerebral cortex | UBERON:0000956 | 49.99 | gold quality |
| frontal cortex | UBERON:0001870 | 49.99 | gold quality |
| nucleus accumbens | UBERON:0001882 | 49.97 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 49.88 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 49.43 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 49.28 | gold quality |
| right frontal lobe | UBERON:0002810 | 49.16 | gold quality |
| putamen | UBERON:0001874 | 48.63 | gold quality |
| ganglionic eminence | UBERON:0004023 | 48.61 | silver quality |
| brain | UBERON:0000955 | 48.57 | gold quality |
| caudate nucleus | UBERON:0001873 | 48.39 | gold quality |
| primary visual cortex | UBERON:0002436 | 47.96 | gold quality |
| hypothalamus | UBERON:0001898 | 46.47 | gold quality |
| tonsil | UBERON:0002372 | 46.24 | gold quality |
| endometrium | UBERON:0001295 | 46.23 | silver quality |
| colonic epithelium | UBERON:0000397 | 45.59 | gold quality |
| amygdala | UBERON:0001876 | 44.14 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.65 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
42 targeting FOXD4L5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-6499-3P | 99.90 | 66.38 | 1212 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-7154-5P | 99.69 | 70.52 | 1900 |
| HSA-MIR-3679-3P | 99.64 | 69.88 | 1599 |
| HSA-MIR-6716-5P | 99.56 | 68.62 | 1244 |
| HSA-MIR-3153 | 99.55 | 67.59 | 2337 |
| HSA-MIR-4761-5P | 99.51 | 66.69 | 804 |
| HSA-MIR-653-5P | 99.46 | 67.35 | 1300 |
| HSA-MIR-130A-5P | 99.33 | 70.26 | 2623 |
| HSA-MIR-12113 | 99.32 | 67.54 | 1072 |
| HSA-MIR-7515 | 99.31 | 68.22 | 1795 |
| HSA-MIR-1206 | 99.30 | 69.32 | 1016 |
| HSA-MIR-3125 | 99.14 | 68.49 | 2269 |
| HSA-MIR-146A-3P | 99.13 | 68.99 | 1881 |
| HSA-MIR-3152-3P | 99.10 | 66.35 | 678 |
| HSA-MIR-6749-3P | 99.00 | 65.73 | 1443 |
| HSA-MIR-3916 | 98.99 | 68.04 | 2155 |
| HSA-MIR-6859-5P | 98.99 | 68.07 | 2049 |
| HSA-MIR-4738-3P | 98.98 | 67.98 | 1846 |
| HSA-MIR-4539 | 98.78 | 67.18 | 888 |
| HSA-MIR-876-3P | 98.76 | 68.23 | 945 |
| HSA-MIR-219A-2-3P | 98.62 | 68.78 | 797 |
| HSA-MIR-31-5P | 98.58 | 68.35 | 1239 |
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Foxd4 | ENSMUSG00000051490 |
Paralogs (41): FOXP3 (ENSG00000049768), FOXC1 (ENSG00000054598), FOXJ2 (ENSG00000065970), FOXF1 (ENSG00000103241), FOXN1 (ENSG00000109101), FOXM1 (ENSG00000111206), FOXP1 (ENSG00000114861), FOXO3 (ENSG00000118689), FOXA2 (ENSG00000125798), FOXA1 (ENSG00000129514), FOXJ1 (ENSG00000129654), FOXK2 (ENSG00000141568), FOXO1 (ENSG00000150907), FOXH1 (ENSG00000160973), FOXQ1 (ENSG00000164379), FOXK1 (ENSG00000164916), FOXD4 (ENSG00000170122), FOXA3 (ENSG00000170608), FOXB1 (ENSG00000171956), FOXR1 (ENSG00000176302), FOXL1 (ENSG00000176678), FOXC2 (ENSG00000176692), FOXE1 (ENSG00000178919), FOXS1 (ENSG00000179772), FOXL2 (ENSG00000183770), FOXO4 (ENSG00000184481), FOXD4L1 (ENSG00000184492), FOXD4L4 (ENSG00000184659), FOXD2 (ENSG00000186564), FOXI2 (ENSG00000186766), FOXE3 (ENSG00000186790), FOXD3 (ENSG00000187140), FOXD4L3 (ENSG00000187559), FOXR2 (ENSG00000189299), FOXJ3 (ENSG00000198815), FOXO6 (ENSG00000204060), FOXB2 (ENSG00000204612), FOXI3 (ENSG00000214336), FOXL3 (ENSG00000248767), FOXD1 (ENSG00000251493)
Protein
Protein identifiers
Forkhead box protein D4-like 5 — Q5VV16 (reviewed: Q5VV16)
All UniProt accessions (1): Q5VV16
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
RefSeq proteins (1): NP_001119806* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001766 | Fork_head_dom | Domain |
| IPR018122 | TF_fork_head_CS_1 | Conserved_site |
| IPR030456 | TF_fork_head_CS_2 | Conserved_site |
| IPR036388 | WH-like_DNA-bd_sf | Homologous_superfamily |
| IPR036390 | WH_DNA-bd_sf | Homologous_superfamily |
| IPR050211 | FOX_domain-containing | Family |
Pfam: PF00250
UniProt features (6 total): region of interest 2, compositionally biased region 2, chain 1, DNA-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VV16-F1 | 57.03 | 0.17 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 20 (showing top):
chr9q21, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR95_5P, MIR4753_3P, MIR130A_5P, MIR7154_5P, MIR6818_3P, MIR31_5P, MIR1206, MIR877_5P, MIR3152_3P, MIR4761_5P, MIR1266_3P, MANNO_MIDBRAIN_NEUROTYPES_HGABA
GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), anatomical structure morphogenesis (GO:0009653), cell differentiation (GO:0030154), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), sequence-specific DNA binding (GO:0043565)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| developmental process | 1 |
| anatomical structure development | 1 |
| cellular developmental process | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| DNA binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
468 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FOXD4L5 | ANKRD20A2P | Q5SQ80 | 652 |
| FOXD4L5 | ZNF595 | Q8IYB9 | 508 |
| FOXD4L5 | POU5F2 | Q8N7G0 | 390 |
| FOXD4L5 | MYO18B | Q8IUG5 | 378 |
| FOXD4L5 | ARHGEF5 | Q12774 | 375 |
| FOXD4L5 | NKX1-1 | Q15270 | 375 |
| FOXD4L5 | NKX1-2 | Q9UD57 | 339 |
| FOXD4L5 | MUC12 | Q9UKN1 | 328 |
| FOXD4L5 | NKX2-4 | Q9H2Z4 | 322 |
| FOXD4L5 | NKX2-6 | A6NCS4 | 320 |
| FOXD4L5 | NKX6-3 | A6NJ46 | 290 |
| FOXD4L5 | FOXR2 | Q6PJQ5 | 277 |
| FOXD4L5 | NKX2-8 | O15522 | 267 |
| FOXD4L5 | POU6F2 | P78424 | 265 |
| FOXD4L5 | SOX14 | O95416 | 263 |
| FOXD4L5 | POU6F1 | Q14863 | 263 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0U1RRK4, A0A1W2PPE3, A0A1W2PR82, A0A2R8Y2Y2, A0A494C0N9, A0A494C0Y3, A0JNN8, A6NF83, A6NHQ4, A6QPM6, A8E4L3, A8MTW9, B2KGE5, C9JVW0, I3L1E1, O43541, O75474, O75638, P0C7X2, P70339, P89439, Q02080, Q05215, Q12950, Q3SYB3, Q5T230, Q5VV16, Q6NZ36, Q6NZY7, Q6P1X6, Q6VB84, Q6VUC0, Q6VUP9, Q6ZSJ8, Q7RTU5, Q7TNS8, Q80WY3, Q86SI9, Q86UU5, Q8K025
Diamond homologs: A0A078BQN7, A0A1W2PRP0, A0A8V0YY16, A1L1S5, A3KNJ3, A8MTJ6, A8XJN7, B5RHS5, D3Z120, F1R8Z9, O00358, O17617, O43638, O54743, O60129, O88470, P32027, P32028, P32030, P32315, P42128, P55316, P56260, P58012, P79772, P85037, P91278, Q00939, Q01167, Q02360, Q12946, Q12947, Q12948, Q12950, Q12951, Q12952, Q13461, Q19802, Q1A1A1, Q1A1A2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
165 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 159 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
45 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:65284460:ATGTT:A | acceptor_gain | 0.5300 |
| 9:65284463:CAACA:C | acceptor_gain | 0.5100 |
| 9:65284481:C:T | acceptor_gain | 0.4600 |
| 9:65284461:TGTTG:T | acceptor_gain | 0.4500 |
| 9:65284462:GTTGC:G | acceptor_gain | 0.4500 |
| 9:65284462:A:AG | acceptor_gain | 0.4400 |
| 9:65284479:TGC:T | acceptor_gain | 0.4200 |
| 9:65284463:T:TC | acceptor_gain | 0.4000 |
| 9:65284464:GCAAC:G | acceptor_gain | 0.4000 |
| 9:65284465:TGCAA:T | acceptor_gain | 0.4000 |
| 9:65285142:A:C | donor_gain | 0.3700 |
| 9:65284461:A:G | acceptor_gain | 0.3500 |
| 9:65285132:C:CA | donor_gain | 0.3500 |
| 9:65285140:T:G | donor_gain | 0.3500 |
| 9:65284479:G:A | acceptor_gain | 0.3400 |
| 9:65285131:G:GT | donor_gain | 0.3400 |
| 9:65284463:T:C | acceptor_gain | 0.3300 |
| 9:65284453:GGGAT:G | acceptor_gain | 0.3000 |
| 9:65284454:GGATG:G | acceptor_gain | 0.3000 |
| 9:65284456:CATCC:C | acceptor_gain | 0.2900 |
| 9:65284457:TCATC:T | acceptor_gain | 0.2900 |
| 9:65284463:TTGC:T | acceptor_gain | 0.2900 |
| 9:65284815:C:T | acceptor_gain | 0.2900 |
| 9:65284813:G:A | acceptor_gain | 0.2800 |
| 9:65285018:C:A | donor_gain | 0.2800 |
| 9:65284462:AACA:A | acceptor_gain | 0.2700 |
| 9:65284455:G:A | acceptor_gain | 0.2600 |
| 9:65282246:C:CG | acceptor_gain | 0.2500 |
| 9:65282291:T:TA | acceptor_gain | 0.2400 |
| 9:65284455:ATCC:A | acceptor_gain | 0.2400 |
AlphaMissense
2674 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:65283832:C:A | W182C | 1.000 |
| 9:65283832:C:G | W182C | 1.000 |
| 9:65283880:G:C | F166L | 1.000 |
| 9:65283880:G:T | F166L | 1.000 |
| 9:65283881:A:C | F166C | 1.000 |
| 9:65283882:A:G | F166L | 1.000 |
| 9:65283787:A:C | F197L | 0.999 |
| 9:65283787:A:T | F197L | 0.999 |
| 9:65283789:A:G | F197L | 0.999 |
| 9:65283802:G:C | F192L | 0.999 |
| 9:65283802:G:T | F192L | 0.999 |
| 9:65283803:A:C | F192C | 0.999 |
| 9:65283804:A:G | F192L | 0.999 |
| 9:65283834:A:G | W182R | 0.999 |
| 9:65283834:A:T | W182R | 0.999 |
| 9:65283881:A:G | F166S | 0.999 |
| 9:65283890:T:A | N163I | 0.999 |
| 9:65283906:G:C | H158D | 0.999 |
| 9:65283911:A:T | I156N | 0.999 |
| 9:65283922:C:A | W152C | 0.999 |
| 9:65283922:C:G | W152C | 0.999 |
| 9:65283924:A:G | W152R | 0.999 |
| 9:65283924:A:T | W152R | 0.999 |
| 9:65283952:G:C | F142L | 0.999 |
| 9:65283952:G:T | F142L | 0.999 |
| 9:65283954:A:G | F142L | 0.999 |
| 9:65283967:G:C | F137L | 0.999 |
| 9:65283967:G:T | F137L | 0.999 |
| 9:65283969:A:G | F137L | 0.999 |
| 9:65283803:A:G | F192S | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000503011 (9:65286323 C>A,G), RS1001041499 (9:65285106 T>A), RS1001751773 (9:65283436 C>A,G), RS1002076765 (9:65282495 A>G), RS1007930470 (9:65284803 C>A,T), RS1009391852 (9:65286465 T>C), RS1017190138 (9:65282663 C>G,T), RS1017515371 (9:65283487 C>A,T), RS1018075710 (9:65283814 G>A), RS1018344940 (9:65284854 C>T), RS1024321638 (9:65282205 GT>G), RS1024753220 (9:65286498 C>T), RS1025293912 (9:65282805 C>A,T), RS1025870625 (9:65283557 G>A,C,T), RS1032062181 (9:65285150 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.